Press releases

2023

March 20

Transparency declaration

March 09

Results as of December 31, 2022

December 21

Transparency declaration

November 22

Placement by GBL of EUR 500 million bonds exchangeable into existing shares of Pernod Ricard SA due 2025

November 21

GBL launches EUR 500 million bonds exchangeable into existing shares of Pernod Ricard SA due 2025

November 03

Results as of September 30, 2022

August 30

Success of GBL’s 7-year bond issue for EUR 500 million

July 29

Results as of June 30, 2022

June 22

GBL successfully completes the sale of approximately 18.1 million shares of Mowi ASA

June 21

GBL launches the sale of up to approximately 18.1 million shares of Mowi ASA

May 31

Report on payments to governments

May 05

Results as of March 31, 2022

April 26

Extraordinary and Ordinary General Shareholders’ Meetings of April 26, 2022

April 20

GBL acquires a majority stake in Sanoptis, a European leader in ophthalmology clinics, to accelerate the company’s growth in partnership with its management and doctors

April 19

GBL makes its first sizeable investment in the healthcare sector with the acquisition of Affidea, the leading provider of medical diagnostic services in Europe

March 25

Extraordinary and Ordinary General Shareholders’ Meetings of April 26, 2022

March 25

Publication of the 2021 Annual Report

March 24

Sienna Investment Managers announces the acquisition of Acofi Gestion

March 16

Sienna and Malakoff Humanis conclude their strategic partnership in the field of savings

March 10

Results as of December 31, 2021

February 07

Transparency declaration

January 19

Transparency declaration

January 12

Press releases

2023

Transparency declaration

Results as of December 31, 2022

Transparency declaration

Placement by GBL of EUR 500 million bonds exchangeable into existing shares of Pernod Ricard SA due 2025

GBL launches EUR 500 million bonds exchangeable into existing shares of Pernod Ricard SA due 2025

Results as of September 30, 2022

Success of GBL’s 7-year bond issue for EUR 500 million

Results as of June 30, 2022

GBL successfully completes the sale of approximately 18.1 million shares of Mowi ASA

GBL launches the sale of up to approximately 18.1 million shares of Mowi ASA

Report on payments to governments

Results as of March 31, 2022

Extraordinary and Ordinary General Shareholders’ Meetings of April 26, 2022

GBL acquires a majority stake in Sanoptis, a European leader in ophthalmology clinics, to accelerate the company’s growth in partnership with its management and doctors

GBL makes its first sizeable investment in the healthcare sector with the acquisition of Affidea, the leading provider of medical diagnostic services in Europe

Extraordinary and Ordinary General Shareholders’ Meetings of April 26, 2022

Publication of the 2021 Annual Report

Sienna Investment Managers announces the acquisition of Acofi Gestion

Sienna and Malakoff Humanis conclude their strategic partnership in the field of savings

Results as of December 31, 2021

Transparency declaration

Transparency declaration

GBL Sets its Sights on Private Assets in German-speaking Markets with the Hire of Jens Riedl

Groupe Bruxelles Lambert (GBL)

Contact

Investor Relations